Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


12.08.2019

1 Am J Dermatopathol
2 Ann Surg Oncol
2 BMC Cancer
2 Br J Dermatol
2 Eur J Dermatol
1 J Cell Physiol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. COMODO-NAVARRO AN, Fernandes M, Barcelos D, Carapeto FCL, et al
    Intratumor Heterogeneity of KIT Gene Mutations in Acral Lentiginous Melanoma.
    Am J Dermatopathol. 2019 Jul 29. doi: 10.1097/DAD.0000000000001475.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. KWAK M, Song Y, Gimotty PA, Farrow NE, et al
    Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis.
    Ann Surg Oncol. 2019 Aug 7. pii: 10.1245/s10434-019-07694.
    PubMed     Text format     Abstract available

  3. EGGER ME, Stevenson M, Bhutiani N, Jordan AC, et al
    Age and Lymphovascular Invasion Accurately Predict Sentinel Lymph Node Metastasis in T2 Melanoma Patients.
    Ann Surg Oncol. 2019 Aug 7. pii: 10.1245/s10434-019-07690.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. DOMA V, Karpathy S, Raso E, Barbai T, et al
    Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma.
    BMC Cancer. 2019;19:786.
    PubMed     Text format     Abstract available

  5. CASULA M, Paliogiannis P, Ayala F, De Giorgi V, et al
    Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
    BMC Cancer. 2019;19:772.
    PubMed     Text format     Abstract available


    Br J Dermatol

  6. VUONG K, Armstrong BK, Drummond M, Hopper JL, et al
    Development and external validation study of a melanoma risk prediction model incorporating clinically-assessed naevi and solar lentigines.
    Br J Dermatol. 2019 Aug 4. doi: 10.1111/bjd.18411.
    PubMed     Text format     Abstract available

  7. FEARFIELD L, Nobbs J, Petruckevitch A, Harland C, et al
    Severe vitamin D deficiency associated with BRAF mutated melanoma.
    Br J Dermatol. 2019 Aug 5. doi: 10.1111/bjd.18413.
    PubMed     Text format     Abstract available


    Eur J Dermatol

  8. BOCQUET-TREMOUREUX S, Scharbarg E, Nguyen JM, Varey E, et al
    Efficacy and safety of nivolumab in metastatic melanoma: real-world practice.
    Eur J Dermatol. 2019;29:315-321.
    PubMed     Text format     Abstract available

  9. ARIANAYAGAM S, Ieremia E, Matin RN
    Delayed skin toxicity associated with pembrolizumab therapy for metastatic melanoma.
    Eur J Dermatol. 2019;29:349-351.
    PubMed     Text format    


    J Cell Physiol

  10. ZHAO G, Yin Y, Zhao B
    miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/beta-catenin and NF-kappaB cascades.
    J Cell Physiol. 2019 Aug 6. doi: 10.1002/jcp.29122.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: